TERN NASDAQ
Terns Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.7%
3M: +40.2%
YTD: +32.0%
1Y: +1647.5%
3Y: +310.5%
5Y: +161.1%
$52.95
Last traded 2026-05-15 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
5 relationships5
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2024-07-03
Earliest Filing
2026-03-25
Latest Filing
partner: 3
acquirer: 2
Counterparties (Filed by TERN)
5 relationshipsCompanies named in TERN's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Merck Sharp & Dohme LLC | MRK | acquirer | Parent company entering into a merger agreement to acquire Terns Pharmaceuticals, Inc. | 2026-03-25 | View |
| Thailand Merger Sub, Inc. | — | acquirer | Wholly owned subsidiary of Merck Sharp & Dohme LLC acting as the Purchaser in the merger. | 2026-03-25 | View |
| Hansoh (Shanghai) Healthtech Co., Ltd. | — | partner | Entered into an amendment to an exclusive option and license agreement for TERN-701 products in mainland China, Taiwan, | 2026-01-22 | View |
| DWF IV Century Plaza, LLC | — | partner | Landlord in office lease amendment agreement | 2024-07-03 | View |
| DivcoWest Real Estate Asset Management, Inc. | — | partner | Agent for Landlord in office lease amendment agreement | 2024-07-03 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-05-05 | Acquisition/Disposition; Delisting Notice; Change in Control; Officer/Director Change; Bylaws Amendm | Acquisition | View |
| 2026-04-27 | Regulation FD; Other Events; Exhibits | View | |
| 2026-03-25 | Material Agreement; Regulation FD; Exhibits | Agreement | View |
| 2026-01-22 | Entry into Material Definitive Agreement | Agreement | View |
| 2026-01-09 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-12-11 | Other Events; Financial Statements and Exhibits | View | |
| 2025-12-08 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-11-10 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-11-03 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-10-22 | Other Events; Financial Statements and Exhibits | View | |
| 2025-08-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-16 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-08 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-03-20 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-02-24 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-02-20 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-02-06 | Departure/Election of Directors; Appointment of Officers | View | |
| 2024-12-03 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2024-11-18 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2024-11-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR